A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

NCT03433482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1707

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis, Meningococcal

Interventions

BIOLOGICAL: MenACWY liquid
BIOLOGICAL: MenACWY

Sponsor

GlaxoSmithKline